Reducing Complications of Influenza: Update on the Use of Antiviral Agents in Vulnerable Patients

Reducing Complications of Influenza: Update on the Use of Antiviral Agents in Vulnerable Patients is organized by Paradigm Medical Communications, LLC.

Release Date: October 28, 2019
Expiration Date: October 28, 2020

Accreditation:
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.0 hours (0.10 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

Learning Objectives:
Upon proper completion of this activity, participants should be better able to:
• Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
• Determine the need for influenza treatment based on patient signs, symptoms, and accurate interpretation of appropriate diagnostic tests when necessary
• Evaluate the latest safety and efficacy data for novel antiviral treatment to determine its role in the influenza treatment paradigm

Additional details will be posted as soon as information is available.